
08/17/2025
Did you know that without treatment, most patients with crescentic Immunoglobulin A Nephropathy (IgAN) progress to end stage kidney disease over time? These patients have a high rate of recurrence post kidney transplant with no current standardized treatment. If you have been diagnosed with crescentic IgAN, you may be eligible for a clinical trial to study a novel form of therapy in the treatment of your disease. For more information, please visit https://mayocl.in/3HvaZjW or contact a member of the research study team at 507-284-0366 or email bendtsen.corbyn@mayo.edu